Lancet Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 2
Professionals
  • Investments
  • 8
  • Exits
  • 5
Exits

Lancet Capital General Information

Description

Lancet Capital is a venture capital firm based in Pittsburgh, Pennsylvania and was founded in 1998. The firm specializes in early-stage investments and seeks to invests in biomedical technologies, bio-informatics, biopharmaceuticals, medical devices, medical information systems, medical therapeutics and diagnostic systems.

Contact Information

Year Founded
1998
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Primary Office
  • 100 Technology Drive
  • Suite 200
  • Pittsburgh, PA 15219
  • United States
+1 (412) 000-0000

Lancet Capital Investments (8)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Biodel 02-Aug-2006 Early Stage VC 0000 Pharmaceuticals Generating Revenue
000000 00000000000 24-Jan-2004 00000 00000 000.00 Other Pharmaceuticals and Biotechnology Generating Revenue/Not Profitable
0000 14-Mar-2003 0000 00.000 Discovery Tools (Healthcare) Generating Revenue
00000 000000000000 29-Jul-2002 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 1
0000000 19-Oct-2000 00000 00000 0000 Diagnostic Equipment Generating Revenue
000000 00000000000 28-Jul-2000 00000 00000 0000 Other Pharmaceuticals and Biotechnology Generating Revenue/Not Profitable
VivoQuest 01-Sep-1998 Seed Round Biotechnology Generating Revenue
Stentor Early Stage VC 000 Diagnostic Equipment Generating Revenue
To view Lancet Capital’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lancet Capital Exits (5)

Company Name Exit Date Exit Type Exit Size
Dyax 22-Jan-2016 Merger/Acquisition 00.00
000000 00000000000 21-Mar-2013 000 0000
000000000 20-Sep-2005 000000000000000000 00.00
Stentor 05-Aug-2005 Merger/Acquisition 00000
Scion Pharmaceuticals 17-Jun-2005 Merger/Acquisition
To view Lancet Capital’s complete exits history, request access »

Lancet Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Lancet Capital Team (2)

Name Title Deals Funds Boards Office
George Sing Managing Director & Co-Founder 0 Cambridge, MA
William Golden Managing Director & Co-Founder Cambridge, MA
To view Lancet Capital’s complete team members history, request access »